Ignite Creation Date:
2025-12-24 @ 2:31 PM
Ignite Modification Date:
2026-01-07 @ 5:39 AM
Study NCT ID:
NCT00519259
Status:
UNKNOWN
Last Update Posted:
2017-01-11
First Post:
2006-06-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tolerability and Safety of 30, 45, and 60 mg of Sublingual Lobeline. - 1
Sponsor:
National Institute on Drug Abuse (NIDA)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-02
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2006-06-29
First Submit QC Date:
None
Study First Post Date:
2007-08-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-01-10
Last Update Post Date:
2017-01-11
Last Update Post Date Type:
ESTIMATED